Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05517655 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

BEGIN Novel ImagiNG Biomarkers

Study acronym: BEGINNING
StatusActive, Not Recruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 30 days later Nov 1, 2028 → Dec 1, 2028
See other at-risk trials from Children's Hospital Medical Center, Cincinnati

Record History

  1. Lead sponsor: Children's Hospital Medical Center, Cincinnati to Children's Hospital Medical Center, Cincinnati Enrollment closed, study ongoing · Primary completion pushed from Nov 1, 2028 to Dec 1, 2028 · Final enrollment: 19 participants (planned 44) · 3 more Show 6 more changesShow less
    • Enrollment closed, study ongoing
    • Primary completion pushed from Nov 1, 2028 to Dec 1, 2028
    • Final enrollment: 19 participants (planned 44)
    • Completion pushed from Nov 1, 2028 to Dec 31, 2029
    • Eligibility criteria expanded, about 19 words
    • Site details revised at 3 of 3 sites
  2. Re-verified, no change to tracked fieldsv3
  3. Primary completion date: Nov 1, 2023 to Nov 1, 2028 Completion date: Nov 1, 2024 to Nov 1, 2028 · Study sites revised (3)v2 Show 2 more changesShow less
    • Completion date: Nov 1, 2024 to Nov 1, 2028
    • Study sites revised (3)

    See this version in full on ClinicalTrials.gov ↗

  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
To determine the treatment effect of triple-combination therapy in 6-8 year olds after presumed FDA approval, using rapid structural and functional pulmonary and abdominal MRI (UTE and 129Xe).
Trial Details
NCT Number NCT05517655
Lead Sponsor Children's Hospital Medical Center, Cincinnati
Collaborators: University of Kansas, University of Iowa, University of Virginia
Conditions Cystic Fibrosis
Enrollment 19 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov